For investors
Earn from portfolio data. Help portfolio companies license their data.
Your portfolio companies hold records AI labs can't find anywhere else. We license that data to AI labs alongside any asset sale, not instead of it, and proceeds go to the company. We work with companies in nine industries, from biotech to insurance.
Where it fits
- Portfolio data reviews
- Asset sales
- Archived programs
Why investors bring us in
A revenue line most portfolios miss.
New revenue
Licensing proceeds go to the company, distributed the way your documents require.
Timing
The earlier we start, the more context we can capture while the people who know the data are still close to it. In biotech, that includes work with CROs.
No conflict with the sale
We plan around any asset sale so licensing never reduces its value.
How a referral works
One email from you.
Introduce us
Connect us with the CEO, CFO, or whoever owns the company's data.
Your part
One intro email.
We assess
We review what data exists, who holds rights to it, and how it fits around any sale.
Your part
Nothing.
License and recover
We license prepared data to AI labs. Proceeds go to the company.
Your part
Stay as involved as you like.
When to call us
The earlier we start, the more context we capture.
- A portfolio data review is underway.
- A program or project is completed or paused.
- Key contracts are approaching their end dates.
- An asset sale process is starting.
- In biotech: a program is paused after a readout.
- In biotech: CRO contracts are coming to an end.
Refer a company
One intro
is all it takes.
We reach out only with your go-ahead.
What happens next
- We'll reply to learn more about the company.
- We reach out to the company only with your go-ahead.